Literature DB >> 19793452

Monkey B virus (Cercopithecine herpesvirus 1).

David Elmore1, Richard Eberle.   

Abstract

Macaques are a particularly valuable nonhuman primate model for a wide variety of biomedical research endeavors. B virus (Cercopithecine herpesvirus 1; BV) is an alpha-herpesvirus that naturally infects conventional populations of macaques. Serious disease due to BV is rare in macaques, but when transmitted to humans, BV has a propensity to invade the central nervous system and has a fatality rate greater than 70% if not treated promptly. The severe consequences of human BV infections led to the inclusion of BV in the original NIH list of target viruses for elimination by development of specific pathogen-free rhesus colonies. In macaques and especially in humans, diagnosis of BV infection is not straightforward. Furthermore, development and maintenance of true BV specific pathogen-free macaque colonies has proven dif cult. In this overview we review the natural history of BV in macaques, summarize what is known about the virus at the molecular level, and relate this information to problems associated with diagnosis of BV infections and development of BV-free macaque colonies.

Entities:  

Mesh:

Year:  2008        PMID: 19793452      PMCID: PMC2703160     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  113 in total

1.  Rapid discrimination of monkey B virus from human herpes simplex viruses by PCR in the presence of betaine.

Authors:  M Hirano; S Nakamura; M Okada; M Ueda; R Mukai
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  Excretion of B virus in monkeys and evidence of genital infection.

Authors:  H T Zwartouw; E A Boulter
Journal:  Lab Anim       Date:  1984-01       Impact factor: 2.471

3.  Oral chemotherapy of fatal B virus (herpesvirus simiae) infection.

Authors:  H T Zwartouw; C R Humphreys; P Collins
Journal:  Antiviral Res       Date:  1989 Jun-Jul       Impact factor: 5.970

4.  Herpes B virus encephalomyelitis presenting as ophthalmic zoster. A possible latent infection reactivated.

Authors:  J Fierer; P Bazely; A I Braude
Journal:  Ann Intern Med       Date:  1973-08       Impact factor: 25.391

5.  Prevalence of Herpesvirus papio 2 in baboons and identification of immunogenic viral polypeptides.

Authors:  R Eberle; D H Black; E L Blewett; G L White
Journal:  Lab Anim Sci       Date:  1997-06

6.  Differential detection of B virus and rhesus cytomegalovirus in rhesus macaques.

Authors:  J L Huff; R Eberle; J Capitanio; S S Zhou; P A Barry
Journal:  J Gen Virol       Date:  2003-01       Impact factor: 3.891

7.  Fatal infection of a pet monkey with Human herpesvirus.

Authors:  Hartwig P Huemer; Clara Larcher; Thomas Czedik-Eysenberg; Norbert Nowotny; Martin Reifinger
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

8.  Disseminated B virus infection in a cynomolgus monkey.

Authors:  M A Simon; M D Daniel; D Lee-Parritz; N W King; D J Ringler
Journal:  Lab Anim Sci       Date:  1993-12

9.  Diagnosis and management of human B virus (Herpesvirus simiae) infections in Michigan.

Authors:  D S Davenport; D R Johnson; G P Holmes; D A Jewett; S C Ross; J K Hilliard
Journal:  Clin Infect Dis       Date:  1994-07       Impact factor: 9.079

10.  Competitive radioimmunoassay to detect antibodies to herpes B virus and SA8 virus.

Authors:  J P Norcott; D W Brown
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

View more
  31 in total

1.  A web-based brain atlas of the vervet monkey, Chlorocebus aethiops.

Authors:  Roger P Woods; Scott C Fears; Matthew J Jorgensen; Lynn A Fairbanks; Arthur W Toga; Nelson B Freimer
Journal:  Neuroimage       Date:  2010-10-13       Impact factor: 6.556

2.  Comparative Risk of Human Injury/Exposure While Collecting Blood from Sedated and Unsedated Nonhuman Primates.

Authors:  Charlotte E Hotchkiss; Melinda A Young
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-06-11       Impact factor: 1.232

3.  Adenocarcinoma of the ileocolic junction and multifocal hepatic sarcomas in an aged rhesus macaque (Macaca mulatta).

Authors:  Cynthia D Lang; Judith S Daviau; Daniel A Merton; Susan M Caraker
Journal:  Comp Med       Date:  2013-08       Impact factor: 0.982

4.  Genistein Has Antiviral Activity against Herpes B Virus and Acts Synergistically with Antiviral Treatments to Reduce Effective Dose.

Authors:  Julia C LeCher; Nga Diep; Peter W Krug; Julia K Hilliard
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

5.  Characterization of ovarian aging and reproductive senescence in vervet monkeys (Chlorocebus aethiops sabaeus).

Authors:  Hannah M Atkins; Cynthia J Willson; Marnie Silverstein; Matthew Jorgensen; Edison Floyd; Jay R Kaplan; Susan E Appt
Journal:  Comp Med       Date:  2014-02       Impact factor: 0.982

6.  Role of the virion host shutoff protein in neurovirulence of monkey B virus (Macacine herpesvirus 1).

Authors:  Darla Black; Jerry Ritchey; Mark Payton; Richard Eberle
Journal:  Virol Sin       Date:  2014-10-22       Impact factor: 4.327

7.  A single viral gene determines lethal cross-species neurovirulence of baboon herpesvirus HVP2.

Authors:  Darla Black; Kazutaka Ohsawa; Shaun Tyler; Lara Maxwell; R Eberle
Journal:  Virology       Date:  2014-01-29       Impact factor: 3.616

8.  Papiine herpesvirus 2 as a predictive model for drug sensitivity of Macacine herpesvirus 1 (monkey B virus).

Authors:  Lauren A Brush; Darla H Black; Kimberly A Mccormack; Lara K Maxwell; George Wright; Jerry W Ritchey; Mark E Payton; Richard Eberle
Journal:  Comp Med       Date:  2014-10       Impact factor: 0.982

9.  Susceptibility of the Aotus nancymaae owl monkey to eastern equine encephalitis.

Authors:  Benjamin J Espinosa; Scott C Weaver; Slobodan Paessler; Douglas Brining; Milagros Salazar; Tadeusz Kochel
Journal:  Vaccine       Date:  2009-01-30       Impact factor: 3.641

10.  Immune-mediated interface dermatitis in a rhesus macaque.

Authors:  L Makaron; K Smith; C Bailey; S Kaliyaperumal; A Miller; J Kramer
Journal:  J Med Primatol       Date:  2012-08-10       Impact factor: 0.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.